Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Behrouz Alirezapour"'
Autor:
Fatemeh Mohammadpour-Ghazi, Hassan Yousefnia, GhasemAli Divband, Samaneh Zolghadri, Behrouz Alirezapour, Fatemeh Shakeri
Publikováno v:
Asia Oceania Journal of Nuclear Medicine and Biology, Vol 11, Iss 2, Pp 135-144 (2023)
Objective(s): Due to the suitable physical characteristics of 89Zr as a PET radionuclide and affinity of Trastuzumab monoclonal antibody against HER2, [89Zr]Zr-Trastuzumab was prepared and went through preclinical evaluations for ultimate human appli
Externí odkaz:
https://doaj.org/article/2a7c5f6ccd5949b6b8976c2ba72cad67
Publikováno v:
Journal of Medical Physics, Vol 47, Iss 3, Pp 287-293 (2022)
Aims: Calculation of the absorbed dose in human organs is one of the first steps for developing new radiopharmaceuticals. The aim of this study is to estimate the human absorbed dose of a newly developed 68Ga-NODAGA-RGD-BBN radiolabeled compound. Mat
Externí odkaz:
https://doaj.org/article/8c1cdce3da024c91a5434bf8bfbfdd01
Publikováno v:
Journal of Medical Physics, Vol 47, Iss 2, Pp 194-200 (2022)
Purpose: In this study, the human absorbed dose of 111In-DOTA-PR81 as a new radioimmunoconjugate for single-photon emission computed tomography (SPECT) imaging of MUC1 + breast cancer was determined. Materials and Methods: The complex was prepared at
Externí odkaz:
https://doaj.org/article/528d459e234c46f987fa56bbf7e12b17
Publikováno v:
Pharmaceutical and Biomedical Research, Vol 2, Iss 2, Pp 31-46 (2016)
PR81 is a monoclonal antibody that binds with high affinity to MUC1 that over expressed on breast tumors. PR81 is considered a suitable targeting molecule that was radiolabeled using Cu-64 for positron imaging studies. The monoclonal antibody was con
Externí odkaz:
https://doaj.org/article/b50ba5952d444ebaaad1f2758713ea04
Autor:
Seyed Mohammad Hosseini, Javad Mohammadnejad, Hassan Yousefnia, Behrouz Alirezapour, Ali Hossein Rezayan
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Autor:
Farahnaz Motamedi Sedeh, Behnaz Piroozfar, Amir Reza Jalilian, Behrouz Alirezapour, Gholamreza Raisali, Miad Hashemizadeh, M. Mirzaii
Publikováno v:
Current Radiopharmaceuticals. 15:148-156
Background: Breast cancer Auger electron therapy is a growing field of study in radioimmunotherapy and oncology research. Trastuzumab, a high affinity-binding monoclonal antibody against HER2/neu is which is over-expressed in breast tumors, is used i
Autor:
Maliheh Hadisi, Naser Vosoughi, Hassan Yousefnia, Ali Bahrami-Samani, Samaneh Zolghadri, Sara Vosoughi, Behrouz Alirezapour
Publikováno v:
Journal of Radioanalytical and Nuclear Chemistry. 331:841-849
Autor:
Samaneh Zolghadri, Nahid Ahmadi, Hassan Yousefnia, Behrouz Alirezapour, Fatemeh Mohammadpour Ghazi, Ali Bahrami-Samani
Publikováno v:
Current Radiopharmaceuticals. 14:154-160
Background: Rheumatoid arthritis (RA) is an inflammatory chronic disease characterized by inflammation, pain, swelling and disability, and radiosynovectomy is one of the disease treatment lines. In this study, the possibility of providing rhenium-186
Publikováno v:
Current radiopharmaceuticals.
Abstract: Angiogenesis phenomenon, as a highly affecting factor on the growth and spread of cancer cells, depends on specific molecular interactions between components of the extracellular matrix and vascular cells. αv integrin acts as a cell adhesi
Autor:
Behrouz Alirezapour, Javad Mohammadnejad, Hassan Yousefnia, Samaneh Zolghadri, Mohammad Javad Rasaee, István Kertész, Sareh Abbas Abadi, Malihe Paknejad
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 64:168-180
In this study, [111 In]In-DOTA-PR81 was developed, and its preliminary preclinical qualifications were assessed for single photon emission computed tomography (SPECT) imaging of breast cancer. DOTA-NHS-ester was practiced and successively purified by